22NW Fund GP, LLC, 10% Owner at LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), sold 97,194 shares at $7.03 ($683K) on 2025-05-12, disclosed to the SEC on 2025-05-12.
Open-market sale of $683k LFCR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 5,098 | $36K | 5.2% |
| 2 | $7.00 | 700 | $5K | 0.7% |
| 3 | $7.03 | 45,698 | $321K | 47.0% |
| 4 | $7.03 | 45,698 | $321K | 47.0% |
| Total | $7.03 avg | 97,194 | $683K | 100% |
| Filing → |
| CULP | BUY | 2024-09-19 | $2.9M | — | Filing → |
| CULP | BUY | 2024-07-10 | $297K | — | Filing → |
| DRTT | BUY | 2021-08-05 | $13.7M | — | Filing → |